Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicentric IIL Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Treatment of Patients With Stage II-IV Follicular Lymphoma

NCT00774826 is registered in ClinicalTrials.gov with Fondazione Italiana Linfomi - ETS as lead sponsor.

NCT NCT00774826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00774826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicentric IIL Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Treatment of Patients With Stage II-IV Follicular Lymphoma
Lead sponsor
Fondazione Italiana Linfomi - ETS
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2005
Completion date
March 31, 2014
Enrollment
534 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma